Mode
Text Size
Log in / Sign up
N/A N=30 Randomized Health Services Research

Controlling Hypertension Outcomes by Improved Communication & Engagement

Hypertension · Stroke

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Apr 2016
Primary outcome: Primary: Patient Activation Measure — 61.33; 60.86; 63.49; 57.45 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Informational Guide for Patients (Other); Video-Assisted Coaching (Behavioral); Monograph for Physicians (Other); Educational Coaching (Behavioral); Control (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Sep 2012

Outcome Measures

OutcomeResultp-value
PRIMARY
Patient Activation Measure
61.33; 60.86; 63.49; 57.45

Summary

This randomized control study tested the feasibility of two communication enhancement interventions: one with veterans who had a stroke and demonstrated poorly controlled hypertension; the other with VA primary care providers who provided routine outpatient medical care to these veterans. This study intervened with both members of the provider-patient dyad in an attempt to improve the self-management of hypertension by improving communication during visits to the VA outpatient clinic, specifically by enabling veterans to communicate their questions and concerns about chronic disease self-management to their providers more effectively, and to help providers improve their ability to communicate more effectively with this population of veterans.

Eligibility Criteria

Inclusion Criteria

Veteran:

  • Veteran is a patient of the enrolled provider
  • History of prior stroke
  • Poorly controlled hypertension with at least one measurement >140/90 mm Hg in the past 12 months
  • Complete a 6-item screen for cognitive and language impairment with a score of 3 or higher
  • Sign the VA Media consent for use of picture and/or voice

Provider:

  • Primary care provider, Medicine Service
  • Sign VA media consent for use of picture and/or voice

Exclusion Criteria

  • Life expectancy is less than 6 months
  • Non-English language patients
  • Inability to provide informed consent
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01134887). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search